NANOSOL Trademark

Trademark Overview

On Wednesday, June 11, 2014, a trademark application was filed for NANOSOL with the United States Patent and Trademark Office. The USPTO has given the NANOSOL trademark a serial number of 86306219. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 13, 2017. This trademark is owned by Ascendia Pharmaceuticals LLC. The NANOSOL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services, namely, production of nanosized drug crystals
nanosol

General Information

Serial Number86306219
Word MarkNANOSOL
Filing DateWednesday, June 11, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 13, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2016

Trademark Statements

Goods and ServicesPharmaceutical drug development services, namely, production of nanosized drug crystals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 20, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAscendia Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNorth Brunswick, NJ 08902
Party NameAscendia Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNorth Brunswick, NJ 08902

Trademark Events

Event DateEvent Description
Monday, March 13, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 13, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 9, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 14, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2016PUBLISHED FOR OPPOSITION
Wednesday, May 25, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 9, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 29, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 28, 2016ASSIGNED TO LIE
Thursday, October 8, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 8, 2015LETTER OF SUSPENSION E-MAILED
Thursday, October 8, 2015SUSPENSION LETTER WRITTEN
Wednesday, October 7, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 7, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 30, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 9, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 9, 2015NON-FINAL ACTION E-MAILED
Thursday, April 9, 2015NON-FINAL ACTION WRITTEN
Thursday, March 19, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 19, 2015ASSIGNED TO LIE
Wednesday, March 11, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 25, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 25, 2014NON-FINAL ACTION E-MAILED
Thursday, September 25, 2014NON-FINAL ACTION WRITTEN
Monday, September 22, 2014ASSIGNED TO EXAMINER
Friday, June 20, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 14, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

nanosol drug nanosized crystals production services development pharmaceutical namely